Navigation Links
C3i and Bristol-Myers Squibb to Discuss the Effects of Oracle Clinical 4.5.3 Zero Footprint on Support Services at the Oracle Health Sciences User Group Conference
Date:10/5/2010

SAN ANTONIO, Texas, Oct. 5 /PRNewswire/ -- C3i, the leader in technology services for the life sciences industry, and Bristol-Myers Squibb (BMS), a leading global biopharmaceutical company, will deliver a joint presentation discussing the advantages realized from upgrading to the newest version of Oracle Clinical/Remote Data Capture (OCRDC) software. The presentation will take place in October during the Oracle Health Sciences User Group conference (OHSUG) in San Antonio, TX October 10-13.

The presentation, titled "The Direct and Indirect Effects Upgrading to Zero Footprint has on Clinical Services", investigates several support areas of interest including site assessment, connectivity, laptop provisioning and software issues. Based on quantitative data gathered from BMS operations, Darlene Kalinowski, Associate Director, EDC Operations at BMS and Warren Ryanes, Account Director at C3i will demonstrate the benefits to clinical trial sponsors of upgrading to OCRDC 4.5.3. The "before" and "after" case study will show improvements in material, time and costs. The two presenters will highlight how a "zero footprint" and a decrease in 3rd party plug-ins results in cost savings in areas as diverse as shipping and connectivity, and in fewer support cases related to data entry, navigation, and reports.

"The Oracle Health Sciences User Group conference is a great place to exchange knowledge on Oracle products and related services .We are excited to share the positive experience of BMS with our colleagues from the industry," said Darlene Kalinowski. Warren Ryanes added: "BMS is a great partner. C3i is delighted to have the opportunity work with Darlene and her team to achieve such excellent results."

About C3i: Headquartered in Morristown, New Jersey, C3i Inc. has global operations centers in the United States, India and Bulgaria. Their 1000 employees provide consulting, systems implementation, technology training, multi-lingual help desk, hardware provisioning and break/fix, asset management, hosting, and user/application administration services for pharmaceutical companies worldwide. To learn more, visit www.c3i-inc.com and follow us on Twitter at http://twitter.com/C3i_Inc.

About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.Contact: Dave Hanaman C3i 973-401-4677 dhanaman@c3i-inc.com
'/>"/>

SOURCE C3i
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
6. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
7. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
8. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
9. VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008
10. Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones
11. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... 25, 2016 , ... The Ankle Plating System 3 and ... address fractures of the distal tibia and fibula. This system marks Acumed's continued ... 3 is composed of seven plate families that span the lateral, medial, and ...
(Date:5/25/2016)... ... May 25, 2016 , ... Lady had been battling arthritis ... cruciate ligament in her left knee. Lady’s owner Hannah sought the help of Dr ... veterinary surgeon, to repair her cruciate ligament and help with the pain of Lady’s ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... identity. The new Media Cybernetics corporate branding reflects a results-driven revitalization for a ... image analysis. The re-branding components include a crisp, refreshed logo and a new ...
(Date:5/23/2016)... LONDON , May 23, 2016 ... Efficiency by 40% - Frontage Implement a Single Platform ... Quality, Compliance and Traceability Within the Bioanalytical lab Frontage ... the United States and China ... across its laboratory facilities. In addition to serving as the global ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):